Lexicon Pharmaceuticals announces principal accounting officer retirement and CMO appointment

LEXICON PHARMACEUTICALS, INC.

James F. Tessmer to retire as VP of finance and accounting (principal accounting officer) effective Sept 24, 2021.
Kristen L. Alexander, current controller, to succeed Tessmer as VP of finance and accounting and principal accounting officer on Sept 24, 2021.
Craig B. Granowitz, M.D., Ph.D., appointed Senior VP and Chief Medical Officer effective Aug 2, 2021; previously CMO of Amarin.
Dr. Granowitz brings prior experience from Merck & Co., Inc. and Schering-Plough Corporation.

item 5.02 item 8.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

James F. Tessmer

vice president of finance and accounting

LXRX · LEXICON PHARMACEUTICALS, INC.

Effective: 2021-09-24
Successor: Kristen L. Alexander
Filed: August 2, 2021, 7:59 PM ET

On July 28, 2021, James F. Tessmer notified us of his decision to retire as our vice president of finance and accounting, effective September 24, 2021.

Appointed

Kristen L. Alexander

vice president of finance and accounting

LXRX · LEXICON PHARMACEUTICALS, INC.

Effective: 2021-09-24
Filed: August 2, 2021, 7:59 PM ET

Effective September 24, 2021, Kristen L. Alexander will become our vice president of finance and accounting and assume the function of our principal accounting officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

James F. Tessmer retired as vice president of finance and accounting at LEXICON PHARMACEUTICALS, INC..

Action: retired
Role: vice president of finance and accounting

Exact text from the filing

On July 28, 2021, James F. Tessmer notified us of his decision to retire as our vice president of finance and accounting, effective September 24, 2021.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Kristen L. Alexander was appointed as vice president of finance and accounting at LEXICON PHARMACEUTICALS, INC..

Action: appointed
Role: vice president of finance and accounting

Exact text from the filing

Effective September 24, 2021, Kristen L. Alexander will become our vice president of finance and accounting and assume the function of our principal accounting officer.

View on SEC.gov

LEXICON PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001062822-21-000046

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.